Drug Company Links 'May Have Compromised Cancer Study'

Three Melbourne oncologists say cancer treatment research published in one of the world's most prestigious medical journals may have been compromised by a drug company that funded the study.

Publication of the research in The Lancet may have boosted the drug's perceived value to doctors and patients around the world, helping its manufacturer, Roche, make billions of dollars from the product, they said.'

Read more...